DZ Bank
TEVA icon

DZ Bank’s Teva Pharmaceuticals TEVA Stock Holding History

DZ Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.5M Buy
1,400,743
+897,812
+179% +$29.9M 0.04% 185
2026
Q1 		$15.1M Buy
502,931
+385,106
+327% +$12.4M 0.01% 324
2025
Q4 		$3.68M Sell
117,825
-384
-0.3% -$9.46K ﹤0.01% 557
2025
Q3 		$2.38M Hold
118,209
– – ﹤0.01% 600
2025
Q2 		$1.98M Buy
118,209
+615
+0.5% +$9.92K ﹤0.01% 596
2025
Q1 		$1.81M Sell
117,594
-800
-0.7% -$14.3K ﹤0.01% 595
2024
Q4 		$2.61M Buy
118,394
+2,644
+2% +$48.1K ﹤0.01% 526
2024
Q3 		$2.08M Sell
115,750
-32,600
-22% -$571K ﹤0.01% 571
2024
Q2 		$2.4M Buy
148,350
+3,900
+3% +$60.1K ﹤0.01% 561
2024
Q1 		$2.04M Sell
144,450
-2,150
-1% -$27.1K ﹤0.01% 582
2023
Q4 		$1.53M Buy
146,600
+6,422
+5% +$60K ﹤0.01% 603
2023
Q3 		$1.42M Sell
140,178
-28,500
-17% -$265K ﹤0.01% 599
2023
Q2 		$1.27M Buy
168,678
+27,570
+20% +$224K ﹤0.01% 628
2023
Q1 		$1.25M Buy
141,108
+2,025
+1% +$20K ﹤0.01% 637
2022
Q4 		$1.27M Buy
139,083
+700
+0.5% +$6.11K ﹤0.01% 660
2022
Q3 		$1.11M Sell
138,383
-7,792
-5% -$68.9K ﹤0.01% 668
2022
Q2 		$1.1M Buy
146,175
+10,075
+7% +$87.8K ﹤0.01% 702
2022
Q1 		$1.28M Sell
136,100
-136,100
-50% -$1.14M ﹤0.01% 690
2021
Q4 		$2.15M Buy
272,200
+136,100
+100% +$1.23M ﹤0.01% 719
2021
Q3 		$1.33M Sell
136,100
-256
-0.2% -$2.4K ﹤0.01% 648
2021
Q2 		$1.35M Buy
136,356
+224
+0.2% +$2.37K ﹤0.01% 648
2021
Q1 		$1.57M Buy
136,132
+32
+0% +$367 ﹤0.01% 589
2020
Q4 		$1.3M Hold
136,100
– – ﹤0.01% 582
2020
Q3 		$1.23M Hold
136,100
– – ﹤0.01% 529
2020
Q2 		$1.68M Sell
136,100
-75,000
-36% -$848K ﹤0.01% 483
2020
Q1 		$1.9M Buy
211,100
+111,856
+113% +$1.15M 0.01% 451
2019
Q4 		$965K Buy
99,244
+344
+0.3% +$3.07K ﹤0.01% 528
2019
Q3 		$680K Sell
98,900
-87,200
-47% -$668K ﹤0.01% 569
2019
Q2 		$1.72M Hold
186,100
– – 0.01% 497
2019
Q1 		$2.92M Sell
186,100
-4,000
-2% -$70.5K 0.01% 429
2018
Q4 		$2.98M Sell
190,100
-84,800
-31% -$1.74M 0.01% 414
2018
Q3 		$5.92M Buy
274,900
+1,000
+0.4% +$23.2K 0.02% 337
2018
Q2 		$6.66M Sell
273,900
-307,000
-53% -$6.26M 0.02% 334
2018
Q1 		$9.92M Buy
580,900
+327,000
+129% +$6.38M 0.04% 292
2017
Q4 		$4.81M Buy
253,900
+112,200
+79% +$1.69M 0.02% 379
2017
Q3 		$2.49M Sell
141,700
-182,400
-56% -$4.1M 0.01% 465
2017
Q2 		$10.8M Sell
324,100
-20,000
-6% -$619K 0.05% 240
2017
Q1 		$11M Buy
344,100
+176,900
+106% +$6.04M 0.05% 240
2016
Q4 		$6.06M Buy
+167,200
New +$6.68M 0.03% 305

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

DZ Bank's TEVA Position: Q2 2026 in Review

DZ Bank increased its Teva Pharmaceuticals (TEVA) stake by 179% in Q2 2026, buying an estimated $29.9M and bringing the position to 1,400,743 shares worth $47.5M. The position accounts for 0.04% of the portfolio, ranked #185.

DZ Bank first reported a position in TEVA in Q4 2016 and has held it in 39 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • DZ Bank held 1,400,743 shares of Teva Pharmaceuticals worth $47.5M as of Q2 2026.
  • DZ Bank bought 897,812 Teva Pharmaceuticals shares in Q2 2026, an estimated $29.9M.
  • Teva Pharmaceuticals made up 0.04% of DZ Bank's portfolio in Q2 2026, its #185 holding.
  • DZ Bank first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.